|
Quote |
Price | |
$3.62 |
|
Price change for today in $ | |
0.09 |
|
Price change for today in % | |
2.55 |
|
Open Price | |
$3.59 |
|
Previous Close | |
$3.53 |
|
Daily Range | |
$3.53 - $3.63 |
|
52-Week Range | |
$1.14 - $3.80 |
|
Volume | |
15,556 |
|
| |
 |
| |
Brokerage Analyst Recommendations
|
| 2 Brokerage Firms Covering AKRX |
| |
|
Strong Buy
2 |
Buy
0 |
Hold
0 |
Sell
0 |
Strong Sell
0 |
|
| Average Broker Recommendation (ABR):1 |
| |
|
| Description |
| Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers, group purchasing organizations and otherpharmaceutical companies. They also provide contract manufacturingservices. |
| |
2500 Millbrook Drive
Buffalo Grove, IL
60089, USA
Phone: 847 279-6100
Fax: 847 279-6123
Web: www.akorn.com
Email: investor.relations@akorn.com |
Industry:MED-GENERIC DRG
Sector: Medical
Fiscal Year End:December
Last Reported Quarter:06/30/10
Next EPS Date:11/09/10 |
|
|
